Laura S Schmidt Selected Research

Neoplasms (Cancer)

7/2022	Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide-chlorambucil conjugate.
1/2021	Tobacco smoking induces metabolic reprogramming of renal cell carcinoma.
1/2021	Clinical and Molecular Characterization of Microphthalmia-associated Transcription Factor (MITF)-related Renal Cell Carcinoma.
1/2021	The tumor suppressor folliculin inhibits lactate dehydrogenase A and regulates the Warburg effect.
11/2020	A FLCN-TFE3 Feedback Loop Prevents Excessive Glycogenesis and Phagocyte Activation by Regulating Lysosome Activity.
1/2020	Tumour predisposition and cancer syndromes as models to study gene-environment interactions.
1/2020	FLCN alteration drives metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary gland.
1/2019	The Metabolic Basis of Kidney Cancer.
1/2019	CDC73 Germline Mutation in a Family With Mixed Epithelial and Stromal Tumors.
1/2019	TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura S Schmidt Research Topics

Disease

33	Neoplasms (Cancer) 07/2022 - 12/2003
20	Kidney Neoplasms (Kidney Cancer) 06/2019 - 08/2004
11	Renal Cell Carcinoma (Grawitz Tumor) 07/2022 - 10/2004
7	Carcinogenesis 07/2022 - 05/2005
6	Birt-Hogg-Dube Syndrome 12/2019 - 10/2006
5	Hypoxia (Hypoxemia) 05/2010 - 07/2006
4	Leiomyoma (Uterine Fibroids) 01/2019 - 07/2003
4	Leiomyomatosis 10/2016 - 01/2007
4	Disease Progression 05/2010 - 01/2007
2	Cysts 01/2020 - 10/2006
2	Hemorrhage 01/2019 - 07/2006
1	Familial renal cell carcinoma 01/2021
1	Hyperparathyroidism 2 01/2019
1	Hyperparathyroidism 01/2019
1	Oxyphilic Adenoma (Oncocytoma) 11/2015
1	Margins of Excision 12/2014
1	Cardiomegaly (Heart Hypertrophy) 11/2014
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 09/2010
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 09/2010
1	Tuberous Sclerosis (Bourneville's Disease) 09/2010
1	Lung Diseases (Lung Disease) 09/2010
1	Emphysema 09/2010
1	Body Weight (Weight, Body) 01/2008
1	Reperfusion Injury 01/2008
1	Starvation 10/2006
1	Hamartoma 10/2006
1	Necrosis 07/2006
1	Hereditary leiomyomatosis and renal cell cancer 07/2003

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 07/2022 - 05/2005
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2005
4	EnzymesIBA 01/2014 - 01/2010
3	Amino Acids FDA Link 11/2020 - 10/2006
3	Sirolimus (Rapamycin)FDA Link 11/2014 - 10/2006
3	Fumarate Hydratase (Fumarase)IBA 01/2014 - 07/2003
3	Messenger RNA (mRNA)IBA 12/2010 - 08/2004
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 11/2020
2	GTP Phosphohydrolases (GTPases)IBA 11/2020 - 10/2015
2	AMP-Activated Protein KinasesIBA 12/2019 - 05/2008
2	IronIBA 01/2019 - 05/2010
2	Oxygen (Dioxygen)IBA 01/2019 - 05/2010
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 10/2016 - 12/2012
2	Mitochondrial DNA (mtDNA)IBA 11/2015 - 09/2014
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2014 - 11/2009
2	TOR Serine-Threonine KinasesIBA 08/2012 - 10/2006
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2010 - 10/2004
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 05/2008 - 10/2006
2	Tamoxifen FDA LinkGeneric 01/2008 - 07/2006
1	Nylons (Nylon)IBA 07/2022
1	Etoposide (VP 16)FDA LinkGeneric 07/2022
1	Chlorambucil (Leukeran)FDA Link 07/2022
1	Indicators and Reagents (Reagents)IBA 07/2022
1	Histidine (L-Histidine)FDA Link 01/2021
1	ArsenicIBA 01/2021
1	Microphthalmia-Associated Transcription FactorIBA 01/2021
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	CopperIBA 01/2021
1	CadmiumIBA 01/2021
1	MetalsIBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	malic acid (malate)IBA 01/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Lactate Dehydrogenase 5IBA 01/2021
1	NucleotidesIBA 01/2020
1	CarcinogensIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 06/2019
1	Biomarkers (Surrogate Marker)IBA 06/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Initiator Codon (Start Codon)IBA 01/2019
1	rab GTP-Binding ProteinsIBA 01/2018
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 11/2015
1	ElementsIBA 11/2014
1	Protein Kinases (Protein Kinase)IBA 09/2013
1	trans-sodium crocetinate (crocetin)IBA 09/2010
1	Vascular Endothelial Growth Factor DIBA 09/2010
1	lipoarabinomannan (LAM)IBA 09/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2010
1	UbiquitinIBA 01/2010
1	Mechanistic Target of Rapamycin Complex 2IBA 11/2009
1	Sorafenib (BAY 43-9006)FDA Link 05/2009
1	Sunitinib (Sutent)FDA Link 05/2009
1	temsirolimus FDA Link 05/2009
1	EndonucleasesIBA 08/2008
1	BuffersIBA 01/2008
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2006
1	CollagenIBA 12/2003

Therapy/Procedure

12	Therapeutics 01/2020 - 01/2007
3	Hysterectomy 01/2019 - 07/2003
1	Precision Medicine 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 12/2014
1	Molecular Targeted Therapy 01/2014
1	Nephrectomy 05/2005